| 摘要 |
This innovation concerns the method of tromboresistant surface treatment of products used in medicine in contact with blood, their treatment by albumin, heparin and glutaric aldehyde solutions, the essence of which rests in the fact the product surface gets alternately submitted 1 to 50 times to the impact of the albumin solution of 0.1 to 0.5 mass % concentration for a duration between 5 and 30 minutes, and of a heparin solution of 50 to 100 mass units/ml concentration for a duration between 5 and 30 minutes while the solutions of pH reach between 3.0 and 4.8 and their ionic potential is less than 0.5, whereupon a final fixation is made by the glutaric aldehyde solution of 0.5 to 1.0 mass 5 concentration.
|
| 申请人 |
BRYNDA EDUARD RNDR. CSC.,CS;HOUSKA MILAN ING. CSC.,CS;VACIK JIRI ING. CSC.,CS;KALAL JAROSLAV PROF. ING. DRSC.,CS;NOVIKOVAESVETLANA P.,SU;ILINA MARINA B.,SU;SELEZNEVA MARINA N.,SU;DOBROVA NATALIA B.,SU |
发明人 |
BRYNDA EDUARD RNDR. CSC.,CS;HOUSKA MILAN ING. CSC.,CS;VACIK JIRI ING. CSC.,CS;KALAL JAROSLAV PROF. ING. DRSC.,CS;NOVIKOVAESVETLANA P.,SU;ILINA MARINA B.,SU;SELEZNEVA MARINA N.,SU;DOBROVA NATALIA B.,SU |
